FDA has cleared a2z Radiology AI's Abdo-Triage tool to triage 10 additional findings on abdomen-pelvis CT scans.
Key Details
- 1a2z Radiology AI Inc. received FDA clearance for its Abdo-Triage software.
- 2The clearance expands the product to flag up to 17 findings on abdomen-pelvis CT images.
- 3A previous clearance was granted in late 2025.
- 4The startup is based in Boston and was founded in 2024.
- 5The product aims to assist clinical teams by triaging a broader range of findings on CT scans.
Why It Matters
This FDA clearance reflects growing regulatory confidence in AI solutions for radiology, offering broader triage of critical findings for abdomen-pelvis CT. It underlines AI’s potential to streamline radiologist workflow and prioritize urgent cases in clinical practice.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
FDA Approves SimBioSys AI Tool for Breast Cancer Risk via MRI
SimBioSys received FDA clearance for TumorSight Risk, an AI tool assessing breast cancer recurrence risk using MRI.